BHIC · XBRL financial data

BioScience Health Innovations financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (BHIC's year ends in late December)

In thousands of dollars	FY 2020Aug 31, 2020	FY 2021Aug 31, 2021	FY 2022Aug 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	0	0	0	598	1,845	5,689
Cost of goods and services sold	—	—	—	113	536	2,448
Gross profit	—	—	—	484	1,309	3,241
Research and development	—	—	—	0	26	161
Selling, general and administrative	8	26	92	706	1,146	2,206
General and administrative	8	—	—	—	—	—
Total operating expenses	8	26	92	736	1,222	2,522
Operating income (loss)	(8)	(26)	(92)	(252)	87	719
Interest expense	—	0	—	—	—	—
Other income (expense)	—	0	9	—	—	—
Income tax expense (benefit)	0	0	0	0	0	77
Net income (loss)	(8)	(26)	(83)	(252)	87	642
Earnings per share, basic USD per share	—	—	—	(0.01)	0.00	0.06
Earnings per share, diluted USD per share	—	—	—	(0.01)	0.00	0.06
Weighted average shares, basic thousands of shares	—	—	—	33,765	41,934	10,979
Weighted average shares, diluted thousands of shares	—	—	—	33,765	42,354	11,399

Fiscal years (BHIC's year ends in late December)

In thousands of dollars	FY 2020Aug 31, 2020	FY 2021Aug 31, 2021	FY 2022Aug 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	21	2	16	19	663	662
Accounts receivable	—	—	—	36	100	399
Inventory	—	—	—	38	58	336
Total current assets	21	6	16	93	848	1,559
Right-of-use asset	—	—	—	—	0	61
Total assets	21	6	16	93	874	1,707
Accounts payable	7	0	2	8	8	6
Accrued liabilities	0	—	—	1	6	8
Total liabilities	8	19	2	100	39	230
Retained earnings (accumulated deficit)	(9)	(34)	(117)	(428)	(341)	301
Total stockholders' equity	13	(13)	14	(7)	835	1,477
Total liabilities and equity	21	6	16	93	874	1,707
Common shares outstanding (cover page) thousands of shares	5,462	5,462	5,462	41,596	43,916	11,367

Fiscal years (BHIC's year ends in late December)

In thousands of dollars	FY 2020Aug 31, 2020	FY 2021Aug 31, 2021	FY 2022Aug 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(8)	(26)	(83)	(252)	87	642
Net cash from operating activities	(8)	(29)	(86)	(308)	23	172
Net cash from investing activities	0	—	—	0	(26)	(57)
Proceeds from issuing common stock	27	0	—	265	755	0
Net cash from financing activities	28	11	100	316	646	(116)

SIC 7374 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 7374 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
BioScience Health Innovations	712	1,036	(542)*	11.8M	1.3 quarters	Q2 FY26 10-QJun 30, 2026
Airwa	11,085	21,244	27,672	4.6M	—	Q1 FY26 10-QJul 31, 2026
Marketwise	32,914	75,808	22,421*	not reported	—	Q2 FY26 10-QJun 30, 2026
Dirtt Environmental Solutions	14,826	40,310	941	194.3M	—	Q2 FY26 10-QJun 30, 2026
Nixxy	330	16,091	(982)*	28.9M	1.8 quarters	Q2 FY26 10-QJun 30, 2026
Healthcare Triangle	1,906	9,193	(833)*	15.0M	2.3 quarters	Q2 FY26 10-QJun 30, 2026
Upland Software	31,044	49,141	5,370*	3.0M	—	Q2 FY26 10-QJun 30, 2026
Veea	1,942	176	(5,932)*	62.2M	0.3 quarters	Q2 FY26 10-QJun 30, 2026
SeeQC	18,116	937	not reported	11.1M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.